Prognostic significance of blood coagulation tests in lung cancer

G. Buccheri, D. Ferrigno, I. Ricca (Cuneo, Italy)

Source: Annual Congress 2001 - Lung cancer: surveys and prognosis
Session: Lung cancer: surveys and prognosis
Session type: Thematic Poster Session
Number: 1594

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Buccheri, D. Ferrigno, I. Ricca (Cuneo, Italy). Prognostic significance of blood coagulation tests in lung cancer. Eur Respir J 2001; 16: Suppl. 31, 1594

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prognostic significance of blood coagulation tests in lung cancer
Source: Eur Respir J 2001; 17: 667-673
Year: 2001



Prognostic significance of plasma D-dimer (DD) in lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 72s
Year: 2002

Is there any diagnostical significance of blood analyses in patients with lung cancer?
Source: Eur Respir J 2005; 26: Suppl. 49, 324s
Year: 2005

Prognostic parameters in patients with lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 84s
Year: 2006

Prognostic and predictive factors for lung cancer
Source: Breathe 2012; 9: 112-122
Year: 2012

Prognostic significance of tumour-related factors in resectable nonsmall-cell lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 131s
Year: 2001

Small cell lung cancer: prognostic significance and correlation with clinical and laboratory parameters
Source: Eur Respir J 2007; 30: Suppl. 51, 670s
Year: 2007

Prognostic factors in patients with lung cancer and brain metastases at presentation
Source: Eur Respir J 2007; 30: Suppl. 51, 670s
Year: 2007

Analysis of surgical stage lung cancer and tumour markers prognostic value
Source: Eur Respir J 2006; 28: Suppl. 50, 770s
Year: 2006

Clinical and prognostic significance of autoantibodies against recoverin in non small cell lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 394s
Year: 2003

Prognostic significance of three tumor markers (CA125, CEA, and TPA) in lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 73s
Year: 2002

Clinicopathological significance and prognostic importance of circulating plasma DNA expression in advanced non-small cell lung cancer and its efficacy as a diagnostic tool
Source: Annual Congress 2012 - New insights in the pathology of lung cancer
Year: 2012

Prognostic significance of MUC1 expression in resected lung adenocarcinoma
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008

Prognostic significance of Nestin in resected non-small cell lung cancer
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010

A meta-analysis assessing the prognostic value of neutrophil to lymphocyte ratio in lung metastasectomy for colorectal cancer
Source: Virtual Congress 2021 – Innovation in thoracic surgery
Year: 2021



Free plasmatic circulating DNA as prognostic and diagnostic lung cancer biomarker
Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases
Year: 2008


Lung function testing for the preoperative evaluation of patients with lung cancer
Source: Annual Congress 2003 - Lung function testing for preoperative evaluation in lung cancer patients
Year: 2003


Prognostic value of neutrophil to lymphocyte ratio in patients with advanced non-small cell lung cancer
Source: Virtual Congress 2021 – Therapy of lung cancer
Year: 2021


Prognostic significance of serum vascular endothelial growth factor and angiopoietin-2 in lung cancer
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013

Evaluation of serum tumour markers in the lung cancer patients
Source: Eur Respir J 2002; 20: Suppl. 38, 268s
Year: 2002